Featured on: Tampa Bay Online
Publication date: Feb 18, 2009
Publication date: Feb 18, 2009
A study by researchers at Wake Forest University School of Medicine has found that two popular anti-inflammatory inhalers may increase by up to 70 percent the risk of pneumonia in patients with chronic obstructive pulmonary disease. The inhalers in the study were Advair, marketed by GlaxoSmithKline, and Symbicort, marketed by AstraZeneca.
Read Full Article
Read Full Article
More Health Articles
Hospitalizations Soar For Kids With Skin InfectionsFacial Analysis Diet May Be Key To Shedding Pounds
Managing High Blood Pressure With Chinese Medicine
High Blood Pressure Declining
Before You Start A Diet Plan, Ponder This Food For Thought
Psoriatic Arthritis Often Unrecognized By Dermatologists
Symptoms Of A Food Allergy
Add Nuts To Your Diet With Sauces, Not Snacks
Second-hand Smoke 'can Increase The Risk Of Dementia'
Staying Fit May Require More Than 30 Min Daily Exercise
